CZ20011872A3 - Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny - Google Patents
Isonipekotamidy pro léčbu onemocnění zprostředkovaných integrinyInfo
- Publication number
- CZ20011872A3 CZ20011872A3 CZ20011872A CZ20011872A CZ20011872A3 CZ 20011872 A3 CZ20011872 A3 CZ 20011872A3 CZ 20011872 A CZ20011872 A CZ 20011872A CZ 20011872 A CZ20011872 A CZ 20011872A CZ 20011872 A3 CZ20011872 A3 CZ 20011872A3
- Authority
- CZ
- Czechia
- Prior art keywords
- isonipecotamides
- integrin
- treatment
- mediated disorders
- mediated
- Prior art date
Links
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical class NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15661799P | 1999-09-29 | 1999-09-29 | |
| US66713400A | 2000-09-21 | 2000-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20011872A3 true CZ20011872A3 (cs) | 2002-03-13 |
Family
ID=26853350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20011872A CZ20011872A3 (cs) | 1999-09-29 | 2000-09-22 | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7718673B2 (cs) |
| EP (1) | EP1133489B9 (cs) |
| CN (1) | CN1352641A (cs) |
| AR (1) | AR034098A1 (cs) |
| AT (1) | ATE300531T1 (cs) |
| AU (1) | AU7711000A (cs) |
| BR (1) | BR0007183A (cs) |
| CA (1) | CA2352957A1 (cs) |
| CZ (1) | CZ20011872A3 (cs) |
| DE (2) | DE60021521T4 (cs) |
| ES (1) | ES2244474T3 (cs) |
| HU (1) | HUP0200439A2 (cs) |
| NO (1) | NO20012612L (cs) |
| NZ (1) | NZ511997A (cs) |
| PL (1) | PL347976A1 (cs) |
| RU (1) | RU2001114518A (cs) |
| WO (1) | WO2001023376A1 (cs) |
| YU (1) | YU22802A (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2151618T3 (es) | 1990-11-19 | 2001-01-01 | Monsanto Co | Inhibidores de proteasas retrovirales. |
| EP1539744A4 (en) | 2002-07-11 | 2007-06-06 | Vicuron Pharm Inc | N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT |
| US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
| PL1734996T3 (pl) | 2004-04-02 | 2013-09-30 | Univ California | Sposoby i kompozycje do leczenia i profilaktyki choroby związanej z integryną alfa v beta 5 |
| WO2009140204A2 (en) * | 2008-05-16 | 2009-11-19 | Allergan, Inc. | Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| KR101752515B1 (ko) | 2009-07-24 | 2017-06-29 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Ａｖｂ５ 인테그린과 결부된 질환의 치료 및 예방을 위한 방법 및 조성물 |
| JP2020505333A (ja) * | 2017-01-09 | 2020-02-20 | アルデリックス， インコーポレイテッド | Ｎｈｅ媒介性アンチポートの阻害薬 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2830555A1 (de) | 1978-07-12 | 1980-03-06 | Bayer Ag | Chinazolinonyl-verbindungen |
| GB8829296D0 (en) | 1988-12-15 | 1989-01-25 | Ici Plc | Anti-tumour compounds |
| JPH04334357A (ja) * | 1991-05-02 | 1992-11-20 | Fujirebio Inc | 酵素阻害作用を有するアシル誘導体 |
| AU3141693A (en) | 1991-11-22 | 1993-06-15 | Friedman, Mark M. | Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| DE4208051A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Substituierte phenylessigsaeureamide |
| CA2150550A1 (en) | 1992-12-01 | 1994-06-09 | Melissa S. Egbertson | Fibrinogen receptor antagonists |
| US6268380B1 (en) | 1993-02-19 | 2001-07-31 | G. D. Searle & Co. | Urea derivatives useful as platelet aggregation inhibitors |
| DE4309867A1 (de) | 1993-03-26 | 1994-09-29 | Cassella Ag | Neue Harnstoffderivate, ihre Herstellung und Verwendung |
| GB9313268D0 (en) | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
| US6380215B1 (en) | 1993-09-22 | 2002-04-30 | Fujisawa Pharmaceutical Co., Ltd | Beta-alanine derivative and a process for the preparation thereof |
| CA2190870A1 (en) | 1994-05-27 | 1995-12-07 | George D. Hartman | Compounds for inhibiting osteoclast-mediated bone resorption |
| US5700801A (en) * | 1994-12-23 | 1997-12-23 | Karl Thomae, Gmbh | Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| AU4432496A (en) * | 1994-12-23 | 1996-07-19 | Dr. Karl Thomae Gmbh | Piperazine derivatives, medicaments containing the same, their use and process for preparing the same |
| US5602155A (en) | 1995-01-17 | 1997-02-11 | G. D. Searle & Co. | Platelet aggregation inhibitors |
| CZ40998A3 (cs) | 1995-08-14 | 1998-09-16 | The Scripps Research Institute | Použití antagonisty anb5 pro výrobu prostředků, schopných inhibovat angiogenezi v tkáních |
| ATE203234T1 (de) | 1995-08-30 | 2001-08-15 | Searle & Co | Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten |
| US6100423A (en) | 1995-08-30 | 2000-08-08 | G. D. Searle & Co. | Amino benzenepropanoic acid compounds and derivatives thereof |
| EP0858457A1 (de) | 1995-10-20 | 1998-08-19 | Dr. Karl Thomae GmbH | 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung |
| DE19548709A1 (de) | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| JP2000515493A (ja) | 1996-03-29 | 2000-11-21 | ジー．ディー．サール アンド カンパニー | パラ―置換フェニレン誘導体 |
| ATE421952T1 (de) | 1996-05-01 | 2009-02-15 | Ortho Mcneil Pharm Inc | Carboxamidderivate von pyrrolidin, piperidin und hexahydropiperizin für behandlung von thrombosen |
| DE19642591A1 (de) | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
| JP3841898B2 (ja) * | 1996-11-21 | 2006-11-08 | 三菱電機株式会社 | 深部線量測定装置 |
| DE69720062D1 (de) | 1996-12-09 | 2003-04-24 | Lilly Co Eli | Integrin antagonisten |
| AR011913A1 (es) | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
| CN1280574A (zh) | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| WO1999025685A1 (en) | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| EP1054871A2 (en) | 1998-04-01 | 2000-11-29 | Du Pont Pharmaceuticals Company | Pyrimidines and triazines as integrin antagonists |
| DK1077941T3 (da) | 1998-05-11 | 2009-12-07 | Novo Nordisk As | Forbindelser med væksthormonfrigörende egenskaber |
| TW591026B (en) * | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
| US6388054B1 (en) | 1998-08-20 | 2002-05-14 | John M. Stewart | Anti-cancer compounds |
| AU2164300A (en) | 1998-12-04 | 2000-06-26 | N.V. Organon | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
| AU6523200A (en) | 1999-08-06 | 2001-03-05 | Smithkline Beecham Corporation | Vitronectin receptor antagonists useful for the treatment of strokes |
| WO2001011002A1 (en) | 1999-08-10 | 2001-02-15 | The Procter And Gamble Company | Nonaqueous liquid detergent with wash-water soluble low-density filler particles |
-
2000
- 2000-09-22 DE DE60021521T patent/DE60021521T4/de not_active Expired - Lifetime
- 2000-09-22 AT AT00966823T patent/ATE300531T1/de not_active IP Right Cessation
- 2000-09-22 AU AU77110/00A patent/AU7711000A/en not_active Abandoned
- 2000-09-22 PL PL00347976A patent/PL347976A1/xx not_active Application Discontinuation
- 2000-09-22 HU HU0200439A patent/HUP0200439A2/hu unknown
- 2000-09-22 CZ CZ20011872A patent/CZ20011872A3/cs unknown
- 2000-09-22 BR BR0007183-8A patent/BR0007183A/pt not_active IP Right Cessation
- 2000-09-22 EP EP00966823A patent/EP1133489B9/en not_active Expired - Lifetime
- 2000-09-22 NZ NZ511997A patent/NZ511997A/xx unknown
- 2000-09-22 CA CA002352957A patent/CA2352957A1/en not_active Abandoned
- 2000-09-22 CN CN00803033A patent/CN1352641A/zh active Pending
- 2000-09-22 DE DE60021521A patent/DE60021521D1/de not_active Expired - Fee Related
- 2000-09-22 RU RU2001114518/04A patent/RU2001114518A/ru not_active Application Discontinuation
- 2000-09-22 WO PCT/US2000/026163 patent/WO2001023376A1/en active IP Right Grant
- 2000-09-22 ES ES00966823T patent/ES2244474T3/es not_active Expired - Lifetime
- 2000-09-28 AR ARP000105121A patent/AR034098A1/es unknown
- 2000-09-29 YU YU22802A patent/YU22802A/sh unknown
-
2001
- 2001-05-28 NO NO20012612A patent/NO20012612L/no not_active Application Discontinuation
-
2003
- 2003-01-16 US US10/345,808 patent/US7718673B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU7711000A (en) | 2001-04-30 |
| ES2244474T3 (es) | 2005-12-16 |
| DE60021521D1 (de) | 2005-09-01 |
| WO2001023376A1 (en) | 2001-04-05 |
| HUP0200439A2 (en) | 2002-06-29 |
| BR0007183A (pt) | 2002-02-05 |
| NO20012612D0 (no) | 2001-05-28 |
| CA2352957A1 (en) | 2001-04-05 |
| PL347976A1 (en) | 2002-05-06 |
| NO20012612L (no) | 2001-07-17 |
| EP1133489A1 (en) | 2001-09-19 |
| US20030181440A1 (en) | 2003-09-25 |
| NZ511997A (en) | 2004-12-24 |
| DE60021521T4 (de) | 2006-09-21 |
| ATE300531T1 (de) | 2005-08-15 |
| US7718673B2 (en) | 2010-05-18 |
| YU22802A (sh) | 2005-06-10 |
| RU2001114518A (ru) | 2003-04-20 |
| CN1352641A (zh) | 2002-06-05 |
| DE60021521T2 (de) | 2006-06-08 |
| AR034098A1 (es) | 2004-02-04 |
| EP1133489B9 (en) | 2006-05-03 |
| EP1133489B1 (en) | 2005-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| PL351134A1 (en) | Compositions for treatment of disorders of the oesophagus | |
| HK1047284A1 (en) | 2-amino-benzoxazinone derivatives for the treatment of obesity | |
| EP1063990A4 (en) | THERAPY FOR ESTROGEN RELATED DISORDERS | |
| AU8187701A (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| HK1053058A1 (zh) | 普拉克索用於治療成癮性疾病的用途 | |
| IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| ZA200107689B (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders. | |
| AU3086900A (en) | Device for the complex treatment of disorders of the prostate | |
| IL157145A0 (en) | Use of dc23 antagonists for the treatment of neoplastic disorders | |
| HUP0201791A2 (en) | The use of escitalopram for treatment of neurotic disorders | |
| EP1126850A4 (en) | TREATMENT OF CONDITIONS OF THE RETINA | |
| PL345769A1 (en) | Triazolopyridines for the treatment of thrombosis disorders | |
| IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
| IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
| IL133760A0 (en) | Composition for the treatment of dandruff | |
| HUP0101947A3 (en) | Combination for the treatment of tumors | |
| CZ20011872A3 (cs) | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny | |
| IL154378A0 (en) | Compounds for the treatment of addictive disorders | |
| ZA200110539B (en) | Oxazinocarbazoles for the treatment of CNS diseases. | |
| HK1043938A1 (en) | Composition for the treatment of psoriasis | |
| SG82014A1 (en) | The use of aryl-cyclohexylamine derivatives against cns disorders | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| GB9924942D0 (en) | Treatment of movement disorders |